ReviewAbdominal radiology (New York)2026
Imaging mimickers of cholangiocarcinoma in the extra-hepatic biliary tree: a pictorial review with diagnostic clues.
Review in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Distal and perihilar biliary strictures and intraductal lesions frequently trigger immediate concern for cholangiocarcinoma (CCA). However, a broad spectrum of benign, inflammatory, infectious, vascular, and extrinsic processes can produce overlapping imaging appearances. Typical CCA of the common bile duct (CBD) commonly manifests as a long, irregular, asymmetric stricture with conspicuous mural thickening and progressive enhancement. These lesions may be accompanied by periductal soft tissue and vascular encasement. In contrast, mimickers more often demonstrate short, smooth, symmetric narrowing; obstructive causes such as stones or periampullary diverticula; extrinsic compression such as lymphadenopathy or portal cavernoma; inflammatory patterns with interval improvement; congenital ductal ectasia; or characteristic systemic/infectious findings. Careful pattern recognition on MRCP and contrast-enhanced MRI and CT integrating stricture morphology, enhancement behavior, vascular relationships, and temporal evolution provide a reliable framework to distinguish malignant CBD cholangiocarcinoma from benign mimics. This review presents a structured approach to differentiate CBD cholangiocarcinoma from key mimickers using MRI/MRCP and CT.
Indexed as
Identifiers
42334599What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.